Tang Capital reports 7.1% stake in Capricor
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Tang Capital Management, LLC and affiliated entities, together with Kevin Tang, report beneficial ownership of 4,099,900 shares of Capricor Therapeutics, Inc. common stock on an amended Schedule 13G. This represents 7.1% of the outstanding common stock, based on 57,911,893 shares outstanding as of May 11, 2026.
The group reports no sole voting or dispositive power and shared voting and dispositive power over all 4,099,900 shares. Tang Capital Partners, LP, Tang Capital Partners International, LP, Tang Capital Partners III, Inc., and Tang Capital Partners IV, Inc. each hold portions of these shares, with Kevin Tang and Tang Capital Management sharing voting and dispositive authority as described.
Key Figures
Key Terms
beneficially owned financial
sole voting power financial
Schedule 13G regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What percentage of Capricor Therapeutics (CAPR) does Tang Capital own?
Who are the reporting persons in the Capricor (CAPR) Schedule 13G/A filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.